CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 232235-232687 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T77039","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T73414","span":{"begin":12,"end":452},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Conclusion: Despite a very high negative predictive value of a negative PCN skin test to the major and minor determinants and reports that no life-threatening false-negative reactions have been reported when PCN is administered after a negative PCN skin test, physicians need to be very cautious in administering piperacillin/tazobactam and other b-lactams in patients with a history of severe reactions such as anaphylaxis to past PCN administrations."}

{"project":"Epistemic_Statements","denotations":[{"id":"T411","span":{"begin":0,"end":452},"obj":"Epistemic_statement"}],"text":"Conclusion: Despite a very high negative predictive value of a negative PCN skin test to the major and minor determinants and reports that no life-threatening false-negative reactions have been reported when PCN is administered after a negative PCN skin test, physicians need to be very cautious in administering piperacillin/tazobactam and other b-lactams in patients with a history of severe reactions such as anaphylaxis to past PCN administrations."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T404","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T405","span":{"begin":12,"end":452},"obj":"Sentence"}],"text":"Conclusion: Despite a very high negative predictive value of a negative PCN skin test to the major and minor determinants and reports that no life-threatening false-negative reactions have been reported when PCN is administered after a negative PCN skin test, physicians need to be very cautious in administering piperacillin/tazobactam and other b-lactams in patients with a history of severe reactions such as anaphylaxis to past PCN administrations."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2120","span":{"begin":412,"end":423},"obj":"Disease"}],"attributes":[{"id":"A2120","pred":"mondo_id","subj":"T2120","obj":"http://purl.obolibrary.org/obo/MONDO_0100053"}],"text":"Conclusion: Despite a very high negative predictive value of a negative PCN skin test to the major and minor determinants and reports that no life-threatening false-negative reactions have been reported when PCN is administered after a negative PCN skin test, physicians need to be very cautious in administering piperacillin/tazobactam and other b-lactams in patients with a history of severe reactions such as anaphylaxis to past PCN administrations."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1050","span":{"begin":412,"end":423},"obj":"Phenotype"}],"attributes":[{"id":"A1050","pred":"hp_id","subj":"T1050","obj":"http://purl.obolibrary.org/obo/HP_0100845"}],"text":"Conclusion: Despite a very high negative predictive value of a negative PCN skin test to the major and minor determinants and reports that no life-threatening false-negative reactions have been reported when PCN is administered after a negative PCN skin test, physicians need to be very cautious in administering piperacillin/tazobactam and other b-lactams in patients with a history of severe reactions such as anaphylaxis to past PCN administrations."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T473","span":{"begin":76,"end":80},"obj":"Body_part"},{"id":"T474","span":{"begin":249,"end":253},"obj":"Body_part"}],"attributes":[{"id":"A473","pred":"uberon_id","subj":"T473","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"id":"A474","pred":"uberon_id","subj":"T474","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"}],"text":"Conclusion: Despite a very high negative predictive value of a negative PCN skin test to the major and minor determinants and reports that no life-threatening false-negative reactions have been reported when PCN is administered after a negative PCN skin test, physicians need to be very cautious in administering piperacillin/tazobactam and other b-lactams in patients with a history of severe reactions such as anaphylaxis to past PCN administrations."}